Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEHIM_CCRT Trial in Cervical Cancer
NCT07439497Phase 2Recruiting
- Sponsor
- Samsung Medical Center
- Start
- Dec 2025
- Primary completion
- May 2026
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132) in Cervical Cancer (CC), sponsored by Samsung Medical Center. Started Dec 2025; status: recruiting.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT07439497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07439497.